Clinical trials in progress
• Intermittent darolutamide trial:
1. Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer? – PMC pmc.ncbi.nlm.nih.gov/articl...
2. Study Details | Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC | ClinicalTrials.gov clinicaltrials.gov/study/NC...
• Intermittent apalutamide trial:
1. Study Details | A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC | ClinicalTrials.gov clinicaltrials.gov/study/NC...
